Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.
Pegram MD, Pienkowski T, Northfelt DW, Eiermann W, Patel R, Fumoleau P, Quan E, Crown J, Toppmeyer D, Smylie M, Riva A, Blitz S, Press MF, Reese D, Lindsay MA, Slamon DJ.
Pegram MD, et al. Among authors: northfelt dw.
J Natl Cancer Inst. 2004 May 19;96(10):759-69. doi: 10.1093/jnci/djh133.
J Natl Cancer Inst. 2004.
PMID: 15150304
Clinical Trial.